![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: IL1R2 |
Gene summary for IL1R2 |
![]() |
Gene information | Species | Human | Gene symbol | IL1R2 | Gene ID | 7850 |
Gene name | interleukin 1 receptor type 2 | |
Gene Alias | CD121b | |
Cytomap | 2q11.2 | |
Gene Type | protein-coding | GO ID | GO:0001816 | UniProtAcc | P27930 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7850 | IL1R2 | HTA11_2487_2000001011 | Human | Colorectum | SER | 5.34e-09 | 7.02e-01 | -0.1808 |
7850 | IL1R2 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.66e-12 | 5.45e-01 | -0.1954 |
7850 | IL1R2 | HTA11_411_2000001011 | Human | Colorectum | SER | 4.50e-04 | 1.07e+00 | -0.2602 |
7850 | IL1R2 | HTA11_2112_2000001011 | Human | Colorectum | SER | 8.02e-07 | 9.57e-01 | -0.2196 |
7850 | IL1R2 | HTA11_83_2000001011 | Human | Colorectum | SER | 8.15e-07 | 5.35e-01 | -0.1526 |
7850 | IL1R2 | HTA11_696_2000001011 | Human | Colorectum | AD | 5.30e-03 | 2.67e-01 | -0.1464 |
7850 | IL1R2 | HTA11_2992_2000001011 | Human | Colorectum | SER | 4.88e-03 | 6.85e-01 | -0.1706 |
7850 | IL1R2 | A015-C-106 | Human | Colorectum | FAP | 3.61e-02 | -8.05e-02 | -0.0511 |
7850 | IL1R2 | LZE2T | Human | Esophagus | ESCC | 3.10e-03 | 1.44e+00 | 0.082 |
7850 | IL1R2 | LZE4T | Human | Esophagus | ESCC | 1.81e-02 | -5.84e-01 | 0.0811 |
7850 | IL1R2 | LZE20T | Human | Esophagus | ESCC | 3.05e-06 | -6.82e-01 | 0.0662 |
7850 | IL1R2 | LZE24T | Human | Esophagus | ESCC | 3.50e-09 | -6.71e-01 | 0.0596 |
7850 | IL1R2 | LZE22D3 | Human | Esophagus | HGIN | 1.44e-09 | 5.86e-01 | 0.0653 |
7850 | IL1R2 | P1T-E | Human | Esophagus | ESCC | 4.27e-03 | -5.49e-01 | 0.0875 |
7850 | IL1R2 | P4T-E | Human | Esophagus | ESCC | 7.75e-13 | -5.65e-01 | 0.1323 |
7850 | IL1R2 | P5T-E | Human | Esophagus | ESCC | 4.16e-22 | -6.77e-01 | 0.1327 |
7850 | IL1R2 | P8T-E | Human | Esophagus | ESCC | 1.85e-13 | -5.70e-01 | 0.0889 |
7850 | IL1R2 | P10T-E | Human | Esophagus | ESCC | 1.23e-41 | 2.45e+00 | 0.116 |
7850 | IL1R2 | P12T-E | Human | Esophagus | ESCC | 1.10e-29 | -5.21e-01 | 0.1122 |
7850 | IL1R2 | P15T-E | Human | Esophagus | ESCC | 2.70e-17 | 2.02e+00 | 0.1149 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0045861 | Colorectum | AD | negative regulation of proteolysis | 106/3918 | 351/18723 | 2.33e-05 | 4.57e-04 | 106 |
GO:0051604 | Colorectum | AD | protein maturation | 85/3918 | 294/18723 | 6.73e-04 | 6.91e-03 | 85 |
GO:0016485 | Colorectum | AD | protein processing | 63/3918 | 225/18723 | 6.77e-03 | 4.19e-02 | 63 |
GO:00458611 | Colorectum | SER | negative regulation of proteolysis | 88/2897 | 351/18723 | 1.74e-06 | 7.50e-05 | 88 |
GO:00516041 | Colorectum | SER | protein maturation | 73/2897 | 294/18723 | 1.82e-05 | 5.38e-04 | 73 |
GO:00164851 | Colorectum | SER | protein processing | 55/2897 | 225/18723 | 2.84e-04 | 4.67e-03 | 55 |
GO:00458614 | Colorectum | FAP | negative regulation of proteolysis | 68/2622 | 351/18723 | 3.07e-03 | 2.31e-02 | 68 |
GO:005160417 | Esophagus | HGIN | protein maturation | 68/2587 | 294/18723 | 9.77e-06 | 2.86e-04 | 68 |
GO:00164857 | Esophagus | HGIN | protein processing | 49/2587 | 225/18723 | 7.04e-04 | 9.52e-03 | 49 |
GO:004586126 | Esophagus | HGIN | negative regulation of proteolysis | 68/2587 | 351/18723 | 2.21e-03 | 2.28e-02 | 68 |
GO:19033173 | Esophagus | HGIN | regulation of protein maturation | 18/2587 | 67/18723 | 3.52e-03 | 3.24e-02 | 18 |
GO:00109553 | Esophagus | HGIN | negative regulation of protein processing | 10/2587 | 29/18723 | 4.07e-03 | 3.65e-02 | 10 |
GO:19033183 | Esophagus | HGIN | negative regulation of protein maturation | 10/2587 | 29/18723 | 4.07e-03 | 3.65e-02 | 10 |
GO:00706133 | Esophagus | HGIN | regulation of protein processing | 17/2587 | 65/18723 | 6.04e-03 | 4.87e-02 | 17 |
GO:005160418 | Esophagus | ESCC | protein maturation | 189/8552 | 294/18723 | 7.64e-11 | 2.39e-09 | 189 |
GO:00607595 | Esophagus | ESCC | regulation of response to cytokine stimulus | 103/8552 | 162/18723 | 3.14e-06 | 3.53e-05 | 103 |
GO:00019595 | Esophagus | ESCC | regulation of cytokine-mediated signaling pathway | 95/8552 | 150/18723 | 9.48e-06 | 9.04e-05 | 95 |
GO:001648514 | Esophagus | ESCC | protein processing | 134/8552 | 225/18723 | 1.81e-05 | 1.60e-04 | 134 |
GO:0045861111 | Esophagus | ESCC | negative regulation of proteolysis | 195/8552 | 351/18723 | 1.13e-04 | 7.85e-04 | 195 |
GO:001095511 | Esophagus | ESCC | negative regulation of protein processing | 20/8552 | 29/18723 | 9.66e-03 | 3.34e-02 | 20 |
Page: 1 2 3 4 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa05418 | Colorectum | AD | Fluid shear stress and atherosclerosis | 54/2092 | 139/8465 | 1.41e-04 | 1.16e-03 | 7.37e-04 | 54 |
hsa05166 | Colorectum | AD | Human T-cell leukemia virus 1 infection | 72/2092 | 222/8465 | 5.24e-03 | 2.44e-02 | 1.55e-02 | 72 |
hsa05215 | Colorectum | AD | Prostate cancer | 35/2092 | 97/8465 | 7.95e-03 | 3.13e-02 | 2.00e-02 | 35 |
hsa054181 | Colorectum | AD | Fluid shear stress and atherosclerosis | 54/2092 | 139/8465 | 1.41e-04 | 1.16e-03 | 7.37e-04 | 54 |
hsa051661 | Colorectum | AD | Human T-cell leukemia virus 1 infection | 72/2092 | 222/8465 | 5.24e-03 | 2.44e-02 | 1.55e-02 | 72 |
hsa052151 | Colorectum | AD | Prostate cancer | 35/2092 | 97/8465 | 7.95e-03 | 3.13e-02 | 2.00e-02 | 35 |
hsa054182 | Colorectum | SER | Fluid shear stress and atherosclerosis | 40/1580 | 139/8465 | 2.28e-03 | 1.75e-02 | 1.27e-02 | 40 |
hsa054183 | Colorectum | SER | Fluid shear stress and atherosclerosis | 40/1580 | 139/8465 | 2.28e-03 | 1.75e-02 | 1.27e-02 | 40 |
hsa054188 | Colorectum | FAP | Fluid shear stress and atherosclerosis | 45/1404 | 139/8465 | 3.05e-06 | 4.63e-05 | 2.81e-05 | 45 |
hsa052152 | Colorectum | FAP | Prostate cancer | 28/1404 | 97/8465 | 1.67e-03 | 8.57e-03 | 5.21e-03 | 28 |
hsa05202 | Colorectum | FAP | Transcriptional misregulation in cancer | 45/1404 | 193/8465 | 9.19e-03 | 3.33e-02 | 2.03e-02 | 45 |
hsa054189 | Colorectum | FAP | Fluid shear stress and atherosclerosis | 45/1404 | 139/8465 | 3.05e-06 | 4.63e-05 | 2.81e-05 | 45 |
hsa052153 | Colorectum | FAP | Prostate cancer | 28/1404 | 97/8465 | 1.67e-03 | 8.57e-03 | 5.21e-03 | 28 |
hsa052021 | Colorectum | FAP | Transcriptional misregulation in cancer | 45/1404 | 193/8465 | 9.19e-03 | 3.33e-02 | 2.03e-02 | 45 |
hsa0541839 | Esophagus | HGIN | Fluid shear stress and atherosclerosis | 42/1383 | 139/8465 | 2.92e-05 | 3.81e-04 | 3.02e-04 | 42 |
hsa05418115 | Esophagus | HGIN | Fluid shear stress and atherosclerosis | 42/1383 | 139/8465 | 2.92e-05 | 3.81e-04 | 3.02e-04 | 42 |
hsa05166211 | Esophagus | ESCC | Human T-cell leukemia virus 1 infection | 164/4205 | 222/8465 | 8.13e-14 | 2.09e-12 | 1.07e-12 | 164 |
hsa05418211 | Esophagus | ESCC | Fluid shear stress and atherosclerosis | 109/4205 | 139/8465 | 2.00e-12 | 3.72e-11 | 1.90e-11 | 109 |
hsa0521516 | Esophagus | ESCC | Prostate cancer | 72/4205 | 97/8465 | 6.12e-07 | 4.10e-06 | 2.10e-06 | 72 |
hsa052028 | Esophagus | ESCC | Transcriptional misregulation in cancer | 116/4205 | 193/8465 | 2.08e-03 | 5.95e-03 | 3.05e-03 | 116 |
Page: 1 2 3 4 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | Breast | DCIS |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | Cervix | ADJ |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | CRC | MSI-H |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | CRC | MSS |
IL1A | IL1R2 | IL1A_IL1R2 | IL1 | Endometrium | AEH |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | Endometrium | AEH |
IL1A | IL1R2 | IL1A_IL1R2 | IL1 | Endometrium | EEC |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | Endometrium | EEC |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | Esophagus | Healthy |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | GC | ADJ |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | GC | GC |
IL1A | IL1R2 | IL1A_IL1R2 | IL1 | HNSCC | ADJ |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | HNSCC | ADJ |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | HNSCC | Healthy |
IL1A | IL1R2 | IL1A_IL1R2 | IL1 | HNSCC | OSCC |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | HNSCC | OSCC |
IL1A | IL1R2 | IL1A_IL1R2 | IL1 | HNSCC | Precancer |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | HNSCC | Precancer |
IL1A | IL1R2 | IL1A_IL1R2 | IL1 | Lung | AAH |
IL1B | IL1R2 | IL1B_IL1R2 | IL1 | Lung | AAH |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
IL1R2 | deletion | Frame_Shift_Del | c.696delA | p.Glu233LysfsTer6 | p.E233Kfs*6 | P27930 | protein_coding | TCGA-EY-A5W2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
IL1R2 | SNV | Missense_Mutation | rs369088604 | c.793G>A | p.Gly265Ser | p.G265S | P27930 | protein_coding | tolerated(0.6) | possibly_damaging(0.638) | TCGA-35-3615-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
IL1R2 | SNV | Missense_Mutation | c.258G>T | p.Met86Ile | p.M86I | P27930 | protein_coding | tolerated(1) | benign(0.013) | TCGA-91-A4BC-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
IL1R2 | SNV | Missense_Mutation | rs753591681 | c.611N>G | p.Tyr204Cys | p.Y204C | P27930 | protein_coding | deleterious(0) | probably_damaging(0.977) | TCGA-39-5037-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | SD |
IL1R2 | SNV | Missense_Mutation | c.16N>T | p.Val6Leu | p.V6L | P27930 | protein_coding | tolerated(0.34) | benign(0.003) | TCGA-63-6202-01 | Lung | lung squamous cell carcinoma | Male | Unknown | I/II | Unknown | Unknown | SD | |
IL1R2 | SNV | Missense_Mutation | rs148522700 | c.16N>A | p.Val6Met | p.V6M | P27930 | protein_coding | tolerated(0.54) | benign(0.01) | TCGA-BR-6706-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5-fluorouracil | PD |
IL1R2 | SNV | Missense_Mutation | c.85N>T | p.Arg29Trp | p.R29W | P27930 | protein_coding | deleterious(0.05) | benign(0) | TCGA-BR-7715-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
IL1R2 | SNV | Missense_Mutation | rs766020542 | c.1040N>T | p.Thr347Met | p.T347M | P27930 | protein_coding | tolerated(0.05) | possibly_damaging(0.791) | TCGA-BR-8380-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | polyplatillen | PD |
IL1R2 | SNV | Missense_Mutation | rs566165327 | c.586N>A | p.Asp196Asn | p.D196N | P27930 | protein_coding | tolerated(1) | benign(0) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR |
IL1R2 | SNV | Missense_Mutation | rs369088604 | c.793N>A | p.Gly265Ser | p.G265S | P27930 | protein_coding | tolerated(0.6) | possibly_damaging(0.638) | TCGA-BR-A4QL-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | xeloda | CR |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
7850 | IL1R2 | DRUGGABLE GENOME | ANAKINRA | ANAKINRA | ||
7850 | IL1R2 | DRUGGABLE GENOME | IL-1 | |||
7850 | IL1R2 | DRUGGABLE GENOME | GSK-1827771 |
Page: 1 |